In this study , a single dose ( @/@ @ - mg ) of the test formulation of irbesartan and hydrochlorothiazide FDC tablet in fasting healthy Chinese male volunteers met WHO 's and China 's FDA regulatory criteria for assumption of bioequivalence to the reference formulation based on AUC and Cmax .